218 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
TSRO TESARO, Inc. $119.05 $6.45B Downtrend
Article Searches
Constellation Pharmaceuticals Readies $80 Million IPO Plans https://seekingalpha.com/article/4186954-constellation-pharmaceuticals-readies-80-million-ipo-plans?source=feed_tag_ipo_analysis Jul 12, 2018 - Constellation Pharmaceuticals intends to sell $80 million of its common stock in a U.S. IPO.The firm is developing treatment candidates for a variety of cancers and myelofibrosis diseases.CNST has sho
Evaluation Of Tesaro: Fair Value And Acquisition Potential https://seekingalpha.com/article/4186853-evaluation-tesaro-fair-value-acquisition-potential?source=feed_sector_healthcare Jul 12, 2018 - Understanding the root cause for the falling stock price in the last 1.5 years.Improved upside for future revenue growth with more indications.Strong pipeline on Immunotherapy assets.Slightly underval
Clovis Gets EU Acceptance for Rubraca Label Expansion Filing http://www.zacks.com/stock/news/310515/clovis-gets-eu-acceptance-for-rubraca-label-expansion-filing?cid=CS-ZC-FT-310515 Jul 06, 2018 - Clovis Oncology's (CLVS) regulatory application seeking label expansion of Rubraca as maintenance treatment was accepted for review in Europe.
Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C. https://seekingalpha.com/article/4178985-stocks-watch-eyes-apples-wwdc-scotus-d-c?source=feed_tag_editors_picks Jun 02, 2018 - Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Tesaro: Can Upcoming Catalyst Bring Fortune To This Unpopular Company? https://seekingalpha.com/article/4178742-tesaro-can-upcoming-catalyst-bring-fortune-unpopular-company?source=feed_sector_healthcare Jun 01, 2018 - Tesaro traded into the deep south for the past 52 weeks. Nevertheless, the fundamentals are improving, thus signaling a trading reversal in the making.Revenues from the approved product, niraparib (Ze
Clovis' Rubraca Gets Approval in Europe for Ovarian Cancer http://www.zacks.com/stock/news/305627/clovis-rubraca-gets-approval-in-europe-for-ovarian-cancer?cid=CS-ZC-FT-305627 May 30, 2018 - Clovis Oncology's (CLVS) PARP inhibitor, Rubraca, gets its first approval in Europe for the treatment of BRCA-mutant ovarian cancer in third- or later-line setting.
Your Daily Pharma Scoop: Cellectis Trial Protocol, Tesaro Takeover Rumor, Kitov Down Before PDUFA https://seekingalpha.com/article/4176403-daily-pharma-scoop-cellectis-trial-protocol-tesaro-takeover-rumor-kitov-pdufa?source=feed_sector_healthcare May 23, 2018 -
Reader Inquiry: Has Tesaro Finally Found A Bottom? https://seekingalpha.com/article/4176387-reader-inquiry-tesaro-finally-found-bottom?source=feed_sector_healthcare May 23, 2018 - The stock has been quite volatile, having lost two-thirds of its value since my initial write-up and at one point rising nearly 250% in 2017. I remind readers that cycles of optimism and pessimism pro
Tesaro (TSRO) Presents At Bank of America Merrill Lynch 2018 Healthcare Conference - Slideshow https://seekingalpha.com/article/4174702-tesaro-tsro-presents-bank-america-merrill-lynch-2018-healthcare-conference-slideshow?source=feed_sector_healthcare May 16, 2018 - The following slide deck was published by Tesaro in conjunction with this event.
Clovis May 2018 Update https://seekingalpha.com/article/4174564-clovis-may-2018-update?source=feed_sector_healthcare May 16, 2018 - Positive CHMP opinion on European approval.Approval in expanded label in USA.A 'bottoming out' of the stock.Comparison of PARPi sales.Maintaining our position in Clovis.

Pages: 123456...22

Page 1>

Related Companies

Name Exchange Price Mkt Cap
IONS Ionis Pharmaceuticals, Inc. NASDAQ $51.33 $6.38B
RDY Dr. Reddy's Laboratories Ltd NYSE $37.66 $6.24B
BIVV Bioverativ Inc. NASDAQ $56.61 $6.12B
ALKS Alkermes plc NASDAQ $50.36 $7.74B
CTLT Catalent, Inc. NYSE $40.76 $5.1B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for TESARO